---

Attenuation of haemodynamic responses of laryngoscopy and endotracheal intubation: An evaluation of efficacy of single intravenous dose of esmolol hydrochloride

Full Text PDF

---

Null

Author Details : Satyendra Yadav*, R S Verma

Volume : 6, Issue : 1, Year : 2019

Article Page : 40-46

https://doi.org/10.18231/2394-4994.2019.0009

Suggest article by email

Get Permission

Abstract

Mitigating stress responses of laryngoscopy and endotracheal intubation is critical in management of general anesthesia patient undergoing surgical intervention. This becomes particularly detrimental and critical in patients with hypertension and cardiovascular cerebral disease affecting immediate and long-term outcomes. Role of beta blockade remained limited due to long duration, irreversibility and rebound withdrawal in acute care settings; which led to discovery of cardioselective short acting esmolol hydrochloride (t1/2- 2.5 to 9 min). In this randomized controlled double-blind prospective trial, we studied intravenous esmolol hydrochloride in 2 different single intravenous bolus doses (Group I - control, Group II - 1mg/Kg, Group III- 1.5mg/kg) in ASA 1 and 2 elective normotensive patients. Statistical analysis was done by using paired-t test. Study concluded that esmolol HCL pretreatment after induction with Thiopental Na before laryngoscopy and intubation allowed unique titration of esmolol doses and monitoring of side effects like bradycardia and hypotension and at the same time significantly attenuated sympatho-adrenal response of rise in pulse, mean arterial pressure (MAP), rate pressure product (RRP) and arrhythmia. Esmolol acts differently in different doses. In 1mg/Kg it effectively controls (P<.001) post intubation rise in pulse. Higher dose of 1.5mg/kg is required to control (P<.001) MAP. Rate pressure product is attenuated in group II (P<.01) and group III (P<.001), indicating that esmolol effectively reduces oxygen consumption by heart and likely prevents ischemia in vulnerable patients. Bradycardia of transient nature is seen in some patients in both test groups, reversed by reducing halothane without any treatment. Perioperative side effects like hypotension and bronchospasm that require stopping the test drug esmolol, were not seen in any of test groups, indicating safety of esmolol in such settings.

Keywords: Anaesthesia, Laryngoscopy endotracheal intubation, Cardiovascular response, Attenuation, Esmolol, Efficacy.

How to cite : Yadav S, Verma R S, Attenuation of haemodynamic responses of laryngoscopy and endotracheal intubation: An evaluation of efficacy of single intravenous dose of esmolol hydrochloride. Indian J Clin Anaesth 2019;6(1):40-46

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.